Global eClinical Solutions Growth Opportunities
Decentralized Clinical Trials, Rising Mobile Health Adoption, and Cloud-based Platforms Lower Costs and Enhance Efficiency
03-Mar-2022
North America
Market Research
$4,950.00
Special Price $3,712.50 save 25 %
The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 and 3 clinical trials. The total number of open trials (recruiting, enrolling by invitations) in 2021 went up 1.8x compared to 2019.
eClinical solutions are the backbone for effectively managing clinical trials end-to-end. The market will register sustained growth at a 14.8% CAGR from 2021, reaching $9,409.5 million by 2026. Cloud-based electronic data capture (EDC), randomization and trial supply management (RTSM)/interactive response technology (IRT), and integrated platforms provide biopharmaceutical sponsors a unified view of the trial workflow while improving efficiency. Beyond the data management and operations products suite, clinical trial IT vendors have the opportunity to create intelligent and connected solutions that focus on decentralized and virtual hybrid trials. Remote patient recruitment and monitoring applications will record significant growth, encompassing patient recruitment, engagement, and monitoring to real-world evidence collection and reporting.
The United States continues to be a dominant market for eClinical solutions, followed by Europe. The rising number of clinical trials, less stringent regulatory guidelines than more developed markets, and large population base in Asia-Pacific offers vendors growth opportunities.
In this report, Frost & Sullivan offers:
• Insights through market forecasts
• Analysis by segment [clinical data management (CDM) and eSourcing, remote patient recruitment and monitoring, and clinical trial operations
management] and region [the United States, Europe, the rest of the world (RoW)]
• Market trends, drivers, and restraints
• Leading participants and their offerings
• Opportunities that stakeholders can pursue over the next 5 years
Author: Amol Dilip Jadhav
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the eClinical Solutions Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Value Chain
Segmentation by Solution
eClinical Solutions Digital Continuity Trend
eClinical Solutions Overview—Remote Patient Recruitment and Monitoring Subsegments
eClinical Solutions Overview—Remote Patient Recruitment and Monitoring Subsegments (continued)
eClinical Solutions Overview—Clinical Data Management and eSourcing
eClinical Solutions Overview—Clinical Data Management and eSourcing Subsegments
eClinical Solutions Overview—Clinical Data Management and eSourcing Subsegments (continued)
eClinical Solutions Overview—Clinical Trial Operations Management Subsegments
eClinical Solutions Overview—Clinical Trial Operations Management Subsegments (continued)
Segmentation by Region
Key Competitors
Key Growth Metrics
Growth Drivers
Growth Restraints
Evolving Clinical Trial Delivery Models
eClinical Solutions Market Trends
eClinical Solutions Market Trends (continued)
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Segment
Revenue Forecast by Region
Pricing Trends and Revenue Forecast Analysis
Pricing Trends and Revenue Forecast Analysis (continued)
Revenue Forecast Analysis by Segment
Revenue Forecast Analysis by Region
Competitive Environment
Revenue Share
Revenue Share Analysis
Mergers and Acquisitions
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Application
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis by Application
Revenue Forecast Analysis by Region
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Application
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis by Application
Revenue Forecast Analysis by Region
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Application
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis by Application
Revenue Forecast Analysis by Region
Growth Opportunity 1—End-to-end Decentralized Clinical Trial (DCT) Platforms to Ensure Interoperability and Scalability
Growth Opportunity 1—End-to-end Decentralized Clinical Trial (DCT) Platforms to Ensure Interoperability and Scalability (continued)
Growth Opportunity 2—Next-generation Telehealth to Enhance Patient Recruitment and Engagement in Clinical Trials
Growth Opportunity 2—Next-generation Telehealth to Enhance Patient Recruitment and Engagement in Clinical Trials (continued)
Growth Opportunity 3—Smartphone-based Remote Monitoring to Collect RWE and Analytics
Growth Opportunity 3—Smartphone-based Remote Monitoring to Collect RWE and Analytics (continued)
Growth Opportunity 4—Cloud-based EDC to Enable a Cost-effective Solution for Large Phase 3 Trials
Growth Opportunity 4—Cloud-based EDC to Enable a Cost-effective Solution for Large Phase 3 Trials (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Deliverable Type | Market Research |
---|---|
No Index | No |
Podcast | No |
Author | Amol Dilip Jadhav |
Industries | Healthcare |
WIP Number | K632-01-00-00-00 |
Keyword 1 | eClinical Solutions |
Keyword 2 | electronic data capture (EDC) |
Keyword 3 | clinical data management (CDM) |
Is Prebook | No |
GPS Codes | 9564-B1,9575-B1,9600-B1,9612-B1,9571-B1,9568-B1,9611-B1 |